Invention Grant
US08236541B2 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
失效
胸苷激酶突变体和具有胸苷激酶和鸟苷酸激酶活性的融合蛋白
- Patent Title: Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
- Patent Title (中): 胸苷激酶突变体和具有胸苷激酶和鸟苷酸激酶活性的融合蛋白
-
Application No.: US12981428Application Date: 2010-12-29
-
Publication No.: US08236541B2Publication Date: 2012-08-07
- Inventor: Margaret E Black
- Applicant: Margaret E Black
- Applicant Address: US WA Bothell
- Assignee: Darwin Molecular Corporation
- Current Assignee: Darwin Molecular Corporation
- Current Assignee Address: US WA Bothell
- Agency: K&L Gates LLP
- Agent C. Rachal Winger
- Main IPC: C12N9/00
- IPC: C12N9/00 ; C12N9/12 ; C12N15/00 ; C07H21/04

Abstract:
The present invention provides isolated nucleic acid molecules encoding a Herpesviridae thymidine kinase enzyme comprising one or more mutations, at least one of the mutations encoding an amino acid substitution located toward the N-terminus from a DRH nucleoside binding site which increases a biological activity of the thymidine kinase, as compared to unmutated thymidine kinase. Such mutations include amino acid substitutions within a Q substrate binding domain which increases a biological activity of the thymidine kinase, as compared to unmutated thymidine kinase. Within a further aspect, fusion proteins are provided which have both guanylate kinase and thymidine kinase biological properties. Also provided are vectors suitable for expressing such DNA molecules, as well as methods for utilizing such vectors.
Public/Granted literature
- US20110165653A1 THYMIDINE KINASE MUTANTS AND FUSION PROTEINS HAVING THYMIDINE KINASE AND GUANYLATE KINASE ACTIVITIES Public/Granted day:2011-07-07
Information query